BioCentury | Jul 25, 2016
Financial News

Mobidiag financial update

...Mobidiag Ltd. , Espoo, Finland Business: Diagnostic Date announced: 2016-07-14 Note: Mobidiag secured a EUR15 million...
...$16.6 million), seven-year loan from the European Investment Bank. The loan will comprise three tranches. Mobidiag...
BioCentury | Jun 15, 2015
Clinical News

Amplidiag H regulatory update

...pylori and resistance to clarithromycin from stool samples. Amplidiag H. pylori+ClariR is a qPCR-based diagnostic. Mobidiag Ltd....
BioCentury | Apr 27, 2015
Clinical News

Amplidiag C regulatory update

...of the hypervirulence-associated 027 ribotype from stool samples. The qPCR-based diagnostic is available in Europe. Mobidiag Ltd....
BioCentury | Sep 29, 2014
Company News

Mobidiag sales and marketing update

...to screen for gastroenteritis-causing bacteria from stool samples. The PCR-based diagnostic has CE Mark approval. Mobidiag Ltd....
BioCentury | Apr 22, 2013
Company News

Amplidiag Oy, Genewave S.A.S., Mobidiag deal

...in a stock deal, with Genewave and Amplidiag becoming subsidiaries of Mobidiag. The newco combines Mobidiag's...
...The combined company is headquartered in Helsinki and has a "center of excellence" in Paris. Mobidiag...
...company also received public funding from Finnish agencies Tekes and Finnvera and from the EU. Mobidiag's...
BioCentury | Dec 21, 2009
Clinical News

Prove-it Sepsis diagnostic data

...has CE mark approval in Europe to diagnose sepsis. Data were published in The Lancet. Mobidiag Ltd....
BioCentury | Jul 13, 2009
Clinical News

Prove-it Herpes regulatory update

...when it expects to launch the microarray assay, which is already marketed for research purposes. Mobidiag Ltd....
BioCentury | May 25, 2009
Clinical News

Prove-it Herpes: Pivotal trial data

...that were not identified by marketed PCR diagnostics. The test is marketed for research purposes. Mobidiag Ltd....
BioCentury | May 25, 2009
Company News

Mobidiag sales and marketing update

...company's StripArray platform, which can analyze up to 96 samples, testing for 64 bacteria, simultaneously. Mobidiag Ltd....
BioCentury | Nov 3, 2008
Company News

Mobidiag sales and marketing update

...identification of sepsis-causing pathogens in blood cultures. The in vitro assay has CE Mark approval. Mobidiag Ltd....
Items per page:
1 - 10 of 13
BioCentury | Jul 25, 2016
Financial News

Mobidiag financial update

...Mobidiag Ltd. , Espoo, Finland Business: Diagnostic Date announced: 2016-07-14 Note: Mobidiag secured a EUR15 million...
...$16.6 million), seven-year loan from the European Investment Bank. The loan will comprise three tranches. Mobidiag...
BioCentury | Jun 15, 2015
Clinical News

Amplidiag H regulatory update

...pylori and resistance to clarithromycin from stool samples. Amplidiag H. pylori+ClariR is a qPCR-based diagnostic. Mobidiag Ltd....
BioCentury | Apr 27, 2015
Clinical News

Amplidiag C regulatory update

...of the hypervirulence-associated 027 ribotype from stool samples. The qPCR-based diagnostic is available in Europe. Mobidiag Ltd....
BioCentury | Sep 29, 2014
Company News

Mobidiag sales and marketing update

...to screen for gastroenteritis-causing bacteria from stool samples. The PCR-based diagnostic has CE Mark approval. Mobidiag Ltd....
BioCentury | Apr 22, 2013
Company News

Amplidiag Oy, Genewave S.A.S., Mobidiag deal

...in a stock deal, with Genewave and Amplidiag becoming subsidiaries of Mobidiag. The newco combines Mobidiag's...
...The combined company is headquartered in Helsinki and has a "center of excellence" in Paris. Mobidiag...
...company also received public funding from Finnish agencies Tekes and Finnvera and from the EU. Mobidiag's...
BioCentury | Dec 21, 2009
Clinical News

Prove-it Sepsis diagnostic data

...has CE mark approval in Europe to diagnose sepsis. Data were published in The Lancet. Mobidiag Ltd....
BioCentury | Jul 13, 2009
Clinical News

Prove-it Herpes regulatory update

...when it expects to launch the microarray assay, which is already marketed for research purposes. Mobidiag Ltd....
BioCentury | May 25, 2009
Clinical News

Prove-it Herpes: Pivotal trial data

...that were not identified by marketed PCR diagnostics. The test is marketed for research purposes. Mobidiag Ltd....
BioCentury | May 25, 2009
Company News

Mobidiag sales and marketing update

...company's StripArray platform, which can analyze up to 96 samples, testing for 64 bacteria, simultaneously. Mobidiag Ltd....
BioCentury | Nov 3, 2008
Company News

Mobidiag sales and marketing update

...identification of sepsis-causing pathogens in blood cultures. The in vitro assay has CE Mark approval. Mobidiag Ltd....
Items per page:
1 - 10 of 13